Chauncey, T. R., Gundacker, H., Shadman, M., List, A. F., Dakhil, S. R., Erba, H. P., . . . Appelbaum, F. R. (2009). Sequential phase II Southwest Oncology Group studies (S0012 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with previously untreated acute myeloid leukemia (AML).
Citação norma ChicagoChauncey, Thomas R., et al. Sequential Phase II Southwest Oncology Group Studies (S0012 and S0301) of Daunorubicin and Cytarabine By Continuous Infusion, Without and With Cyclosporine, in Older Patients With Previously Untreated Acute Myeloid Leukemia (AML). 2009.
Citação norma MLAChauncey, Thomas R., et al. Sequential Phase II Southwest Oncology Group Studies (S0012 and S0301) of Daunorubicin and Cytarabine By Continuous Infusion, Without and With Cyclosporine, in Older Patients With Previously Untreated Acute Myeloid Leukemia (AML). 2009.